Mayne Pharma Group Ltd. (MAYNF)
2.00
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Mayne Pharma Group Cash from Operations (TTM) : 10.97M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.97M |
| December 31, 2025 | 15.30M |
| June 30, 2025 | 13.26M |
| December 31, 2024 | 2.973M |
| June 30, 2024 | -6.144M |
| December 31, 2023 | -5.962M |
| June 30, 2023 | -28.80M |
| December 31, 2022 | -47.94M |
| June 30, 2022 | -12.00M |
| December 31, 2021 | 1.892M |
| June 30, 2021 | 34.49M |
| December 31, 2020 | 59.87M |
| June 30, 2020 | 66.99M |
| December 31, 2019 | 72.90M |
| June 30, 2019 | 75.27M |
| December 31, 2018 | 95.38M |
| June 30, 2018 | 94.04M |
| December 31, 2017 | 76.55M |
| June 30, 2017 | -11.45M |
| Date | Value |
|---|---|
| December 31, 2016 | -33.74M |
| June 30, 2016 | 38.90M |
| December 31, 2015 | 32.97M |
| June 30, 2015 | 18.43M |
| December 31, 2014 | 18.03M |
| June 30, 2014 | 24.00M |
| December 31, 2013 | 20.22M |
| June 30, 2013 | 6.941M |
| December 31, 2012 | 9.754M |
| June 30, 2012 | 13.81M |
| December 31, 2011 | 7.674M |
| June 30, 2011 | 4.151M |
| December 31, 2010 | 8.631M |
| June 30, 2010 | 9.117M |
| December 31, 2009 | 0.2467M |
| June 30, 2009 | -2.665M |
| December 31, 2008 | -3.253M |
| June 30, 2008 | -2.720M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Percheron Therapeutics Ltd. | -3.485M |
| Starpharma Holdings Ltd. | -2.255M |
| Neuren Pharmaceuticals Ltd. | 6.411M |
| Acrux Ltd. | 0.7159M |
| Zelira Therapeutics Ltd. | -3.113M |